AstraZeneca PLC (LSE:AZN) - Share price


Stock Report

AstraZeneca PLC AZN

Latest Morningstar Commentary
DateAuthor Headline
29/10/2019James Gard Brexit Investment Strategies for Uncertain Times
With a General Election slated for December and Brexit postponed until 2020, investors should consider how their portfolios are positioned for more months of uncertainty 
24/07/2019James Gard Glaxo's Vaccines Division Outperforms
FTSE 100 dividend stalwart posts steady results in the first six months and expects better performance in the second half, during which the joint venture with Pfizer will complete
28/12/2018David Brenchley 5 Worst-Performing FTSE 100 Stocks in 2018
The FTSE 100 has suffered from numerous troubles in 2018 - hit by trade and political uncertainty. We round up the worst performers
27/12/2018David Brenchley 5 Best FTSE 100 Stocks of 2018
It has been a troubled year for UK stocks, with fewer than a third of the FTSE 100 constituents in the green. We round up the best performers
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.